Immersive 3D exposure-based treatment for spider fear: A randomized controlled trial.


Journal

Journal of anxiety disorders
ISSN: 1873-7897
Titre abrégé: J Anxiety Disord
Pays: Netherlands
ID NLM: 8710131

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 26 12 2018
medline: 11 2 2020
entrez: 25 12 2018
Statut: ppublish

Résumé

Stereoscopic 3D gives the viewer the same shape, size, perspective and depth they would experience viewing the real world and could mimic the perceptual threat cues present in real life. This is the first study to investigate whether an immersive stereoscopic 3D video exposure-based treatment would be effective in reducing fear of spiders. Participants with a fear of spiders (N = 77) watched two psychoeducational videos with facts about spiders and phobias. They were then randomized to a treatment condition that watched a single session of a stereoscopic 3D immersive video exposure-based treatment (six 5-minute exposures) delivered through a virtual reality headset or a psychoeducation only control condition that watched a 30-minute neutral video (2D documentary) presented on a computer monitor. Assessments of spider fear (Fear of Spiders Questionnaire [FSQ], Behavioral Approach Task [BAT], & subjective ratings of fear) were completed pre- and post-treatment. Consistent with prediction, the stereoscopic 3D video condition outperformed the control condition in reducing fear of spiders showing a large between-group change effect size on the FSQ (Cohen's d = 0.85) and a medium between-group effect size on the BAT (Cohen's d = 0.47). This provides initial support for stereoscopic 3D video in treating phobias.

Identifiants

pubmed: 30580896
pii: S0887-6185(18)30519-X
doi: 10.1016/j.janxdis.2018.12.003
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

37-44

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Sean Minns (S)

Department of Psychology, The University of Texas at Austin, 108 E Dean Keeton St, Austin, TX, 78712, USA.

Andrew Levihn-Coon (A)

Department of Psychology, The University of Texas at Austin, 108 E Dean Keeton St, Austin, TX, 78712, USA.

Emily Carl (E)

Department of Psychology, The University of Texas at Austin, 108 E Dean Keeton St, Austin, TX, 78712, USA. Electronic address: emilycarl@utexas.edu.

Jasper A J Smits (JAJ)

Department of Psychology, The University of Texas at Austin, 108 E Dean Keeton St, Austin, TX, 78712, USA.

Wayne Miller (W)

UT3D Program, 2504 Whitis Ave, Austin, TX, 78705, USA.

Don Howard (D)

Department of Radio-Television-Film, The University of Texas at Austin, 2504 Whitis Ave, Austin, TX, 78705, USA; UT3D Program, 2504 Whitis Ave, Austin, TX, 78705, USA.

Santiago Papini (S)

Department of Psychology, The University of Texas at Austin, 108 E Dean Keeton St, Austin, TX, 78712, USA.

Simon Quiroz (S)

UT3D Program, 2504 Whitis Ave, Austin, TX, 78705, USA; Department of Radio-Television-Film, The University of Texas at Austin, 2504 Whitis Ave, Austin, TX, 78705, USA.

Eunjung Lee-Furman (E)

Department of Psychology, The University of Texas at Austin, 108 E Dean Keeton St, Austin, TX, 78712, USA.

Michael Telch (M)

Department of Psychology, The University of Texas at Austin, 108 E Dean Keeton St, Austin, TX, 78712, USA.

Per Carlbring (P)

Stockholm University, SE-106 91, Stockholm, Sweden.

Drew Xanthopoulos (D)

UT3D Program, 2504 Whitis Ave, Austin, TX, 78705, USA; Department of Radio-Television-Film, The University of Texas at Austin, 2504 Whitis Ave, Austin, TX, 78705, USA.

Mark B Powers (MB)

Department of Psychology, The University of Texas at Austin, 108 E Dean Keeton St, Austin, TX, 78712, USA; Baylor University Medical Center, 3500 Gaston Ave, Dallas, TX, 75246, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH